These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 138687)

  • 1. Virilizing adrenal tumor in a child suppressed with dexamethasone for three years. Effect of o,p'-DDD on serum and urinary androgens.
    Korth-Schutz S; Levine LS; Roth JA; Saenger P; New MI
    J Clin Endocrinol Metab; 1977 Mar; 44(3):433-9. PubMed ID: 138687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dehydroepiandrosterone sulfate (DS) levels, a rapid test for abnormal adrenal androgen secretion.
    Korth-Schutz S; Levine LS; New MI
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1005-13. PubMed ID: 180041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery of adrenal function after treatment of adrenocortical carcinoma with o,p'-DDD.
    Greig F; Oberfield SE; Levine LS; Ghavimi F; Pang S; New MI
    Clin Endocrinol (Oxf); 1984 Apr; 20(4):389-99. PubMed ID: 6325050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of o,p'-DDD on adrenal steroid replacement therapy requirements.
    Robinson BG; Hales IB; Henniker AJ; Ho K; Luttrell BM; Smee IR; Stiel JN
    Clin Endocrinol (Oxf); 1987 Oct; 27(4):437-44. PubMed ID: 2830062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of virilizing adrenal tumors in hirsute women.
    Derksen J; Nagesser SK; Meinders AE; Haak HR; van de Velde CJ
    N Engl J Med; 1994 Oct; 331(15):968-73. PubMed ID: 8084355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic adrenal cortical carcinoma: biochemical changes accompanying clinical regression during therapy with o,p'-DDD.
    Helson L; Wollner N; Murphy ML; Schwartz MK
    Clin Chem; 1971 Dec; 17(12):1191-3. PubMed ID: 4330217
    [No Abstract]   [Full Text] [Related]  

  • 7. Androgen studies in virilism secondary to an adrenal adenoma and to congenital adrenal hyperplasia.
    Osborn RH; Yannone ME; Bradbury JT
    Obstet Gynecol; 1969 May; 33(5):658-65. PubMed ID: 4238091
    [No Abstract]   [Full Text] [Related]  

  • 8. Mitotane (o,p'-DDD) resistance in a dog with pituitary-dependent hyperadrenocorticism and phaeochromocytoma.
    Bennett PF; Norman EJ
    Aust Vet J; 1998 Feb; 76(2):101-3. PubMed ID: 9578778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of virilization to feminization in a young girl with adrenal cortical carcinoma.
    Halmi KA; Lascari AD
    Cancer; 1971 Apr; 27(4):931-5. PubMed ID: 5574080
    [No Abstract]   [Full Text] [Related]  

  • 10. Adrenal and sex steroid hormone production by a virilizing adrenal adenoma and its diagnosis with computerized tomography.
    Ho Yuen B; Moon YS; Mincey EK; Li D
    Am J Obstet Gynecol; 1983 Jan; 145(2):164-9. PubMed ID: 6217751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.
    Pang S; MacGillivray M; Wang M; Jeffries S; Clark A; Rosenthal I; Wiegensberg M; Riddick L
    J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of 16-androstenes in an infant with virilizing adrenal carcinoma.
    Gregory T; Gardner LI; Gower DB; Bicknell DC; Barlow MJ
    Am J Dis Child; 1979 Mar; 133(3):294-7. PubMed ID: 154837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women.
    Barnes RB; Rosenfield RL; Ehrmann DA; Cara JF; Cuttler L; Levitsky LL; Rosenthal IM
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1328-33. PubMed ID: 7962325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen-secreting adrenal tumors.
    Sciarra F; Tosti-Croce C; Toscano V
    Minerva Endocrinol; 1995 Mar; 20(1):63-8. PubMed ID: 7651284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrhenoblastoma associated with adrenal androgenic hyperfunction.
    Cruikshank DP; Yannone ME; Chapler FK
    Obstet Gynecol; 1974 Apr; 43(4):535-8. PubMed ID: 4361441
    [No Abstract]   [Full Text] [Related]  

  • 16. Peripheral steroid levels in a patient with virilizing adrenal adenoma.
    Chakmakjian ZH; Abraham GE
    Obstet Gynecol; 1975 Nov; 46(5):544-8. PubMed ID: 127956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virilizing adrenal adenoma in an adult with the Beckwith-Wiedemann syndrome: paradoxical response to dexamethasone.
    Clouston WM; Cannell GC; Fryar BG; Searle JW; Martin NI; Mortimer RH
    Clin Endocrinol (Oxf); 1989 Oct; 31(4):467-73. PubMed ID: 2534067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete remission of metastasized adrenocortical carcinoma under o,p'-DDD.
    Kornely E; Schlaghecke R
    Exp Clin Endocrinol; 1994; 102(1):50-3. PubMed ID: 8005209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of congenital adrenal hyperplasia using serum dehydroepiandrosterone sulfate and 17-hydroxyprogesterone concentrations.
    Golden MP; Lippe BM; Kaplan SA; Lavin N; Slavin J
    Pediatrics; 1978 Jun; 61(6):867-71. PubMed ID: 149950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adrenocortical adenoma in a 2 1/2 year old girl causing virilization and accelerated growth. Clinical and morphological results (author's transl)].
    Wiebel J; Mitschke H; Richter E; Willig RP
    Monatsschr Kinderheilkd (1902); 1977 Feb; 125(2):104-9. PubMed ID: 190531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.